Diaper [napkin] dermatitis

L12_DIAPER

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L22 Hospital discharge: ICD-9 — 6910 Cause of death: ICD-10 — L22 Cause of death: ICD-9 — 6910 2 out of 7 registries used, show all original rules.	63
4. Check minimum number of events None	63
5. Include endpoints None	63
6. Filter based on genotype QC (FinnGen only)	55

Control definitions (FinnGen only)

Control exclude: L12_DERMATITISECZEMA

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L20-L30
Name in latin: Dermatitis glutealis infantum

NAME	L12_DIAPER
CONTROL_EXCLUDE	L12_DERMATITISECZEMA
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L22
HD_ICD_9	6910
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L22
COD_ICD_9	6910
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Diaper [napkin] dermatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	1887	1086	800
Only index persons	809	478	331
Unadjusted period prevalence (%)
Whole population	0.03	0.03	0.02
Only index persons	0.02	0.02	0.01
Median age at first event (years)
Whole population	1.03	1.01	0.96
Only index persons	1.14	1.10	1.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	55	37	18
Unadjusted period prevalence (%)	0.01	0.01	0.01
Median age at first event (years)	2.62	2.58	2.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
61: Matched controls
610

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

L22

ICD-10 Finland

Diaper [napkin] dermatitis

+∞

62.7

L20.0

ICD-10 Finland

Besnier prurigo

+∞

13.0

6910A

ICD-9 Finland

Atopic dermatitis and related conditions, Diaper or napkin rash

+∞

11.8

E0000UV, ,

ATC

5.4

9.6

151

TQW80

NOMESCO Finland

Local dermatologic skincare

+∞

7.4

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

13.1

6.6

L27.2

ICD-10 Finland

Dermatitis due to ingested food

+∞

6.3

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

+∞

6.3

A28

ICPC

Limited function/disability NOS

4.7

6.2

D07AA02

ATC

hydrocortisone; topical

4.7

6.2

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(40758558) Short blood count panel - Blood

170

3.05

4.40

6.5

10.4

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

6.89

3.63

1.6

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

6.89

3.63

1.6

1.3

—

(3027945) Reticulocytes/Erythrocytes in Blood

3.13

3.62

3.4

8.5

1.40

1.54

0.28

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

104

2.74

3.26

3.7

4.3

4.07

1.05

e6/l

0.94

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

185

2.53

3.14

7.2

4.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

4.83

3.13

1.1

1.2

—

(40761535) Cells panel - Urine sediment

4.40

2.91

8.6

3.3

—

(3000991) Gas panel - Venous blood

2.70

2.82

10.6

17.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

5.49

2.81

1.3

7.1

4.14

3.34

mmol/l

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

318

2.58

2.71

11.8

13.2

3.86

3.90

e9/l

0.04

258

(3030467) Casts [#/volume] in Urine by Automated count

162

2.35

2.64

6.2

4.5

0.03

0.18

e6/l

1.49

120

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

4.79

2.55

1.3

6.4

375.57

603.13

mg/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

3.21

2.50

2.4

2.6

—

(3023368) Bacteria identified in Blood by Culture

105

2.35

2.30

5.8

4.8

—

(3002582) Erythrocytes [#/volume] in Urine

187

2.19

2.30

6.6

4.6

23.21

360.37

e6/l

0.49

145

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

5.93

2.25

5.4

5.1

13.54

9.71

mg/l

—

(3016018) Differential panel - Cerebral spinal fluid

5.93

2.25

1.2

7.8

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.52

2.20

2.8

1.8

—

(3026008) Bacteria identified in Urine by Culture

147

2.19

6.5

2.7

—

(3012544) pH of Venous blood

2.32

2.05

11.2

15.5

7.38

0.03

(42870588) Differential panel, method unspecified - Blood

212

2.07

2.03

10.8

10.6

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

135

2.13

2.00

6.8

4.0

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

127

2.15

1.99

4.4

3.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3.13

1.94

1.3

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2.84

1.89

12.9

5.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

3.30

1.86

3.1

3.3

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

106

2.15

1.86

4.0

4.2

0.45

0.46

e6/l

0.01

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2.91

1.80

1.8

7.1

165.63

171.27

—

(3044290) Cell count panel - Cerebral spinal fluid

4.09

1.75

1.4

7.7

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

230

1.95

1.74

4.2

3.6

—

estimate

—

(3018095) Leukocytes [#/volume] in Urine

223

1.91

1.67

8.2

5.6

56.36

45.82

e6/l

0.10

153

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

187

1.92

1.66

2.2

1.9

—

(21494815) CD4 cells/Lymphocytes in Specimen

3.79

1.65

2.4

6.6

44.18

39.16

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

215

1.90

1.63

6.6

8.8

8.94

21.42

umol/l

4.02

205

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

3.21

1.62

1.2

1.9

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2.19

1.59

3.5

3.9

1161.44

926.51

ng/l

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

3.53

1.55

2.0

6.2

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

3.53

1.55

2.0

6.2

8.20

7.40

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.07

1.47

14.5

19.3

25.67

24.53

mmol/l

0.45

(3014148) Varicella zoster virus Ab [Titer] in Serum

3.11

1.38

1.4

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

3.11

1.38

5.0

30.9

13.74

15.36

—

(3000494) Fungus identified in Specimen by Culture

2.18

1.32

2.0

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

128

1.84

1.30

1.9

2.7

47.75

95.19

u/l

0.80

122

(3044640) Blood type and Crossmatch panel - Blood

163

1.78

1.29

4.5

3.4

—

(4035726) Immunohistochemistry procedure

2.33

1.27

1.4

1.7

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1.99

1.22

7.3

3.9

2.31

2.41

g/l

0.23

(3031040) Bacteria [#/volume] in Urine by Automated count

329

1.75

1.19

9.7

5.0

—

26.83

—

(3042936) Bacteria identified in Isolate by Culture

2.02

1.19

2.4

2.3

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

2.15

1.19

4.1

2.1

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2.15

1.19

18.0

6.5

132.20

56.54

ng/l

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2.63

1.17

8.4

27.4

25.00

23.50

mmol/l

—

(3018418) pH of Serum or Plasma

132

1.77

1.17

10.3

3.7

7.39

0.01

(3019150) Specific gravity of Urine by Refractometry

107

1.82

1.15

7.4

3.9

1.02

kg/l

0.49

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.86

1.13

1.3

1.5

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2.09

1.13

2.8

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

108

1.80

1.12

1.7

3.5

1.38

1.28

mg/l

0.05

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.50

1.11

1.8

1.3

—

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

2.50

1.11

7.2

4.7

56.60

57.89

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.50

1.11

2.2

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

293

1.67

1.09

9.0

9.4

6.71

6.20

mmol/l

0.33

264

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

2.06

1.08

4.2

2.0

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2.06

1.08

2.1

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

1.84

1.05

5.5

5.6

300.86

320.24

umol/l

0.33

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

2.26

0.94

12.5

18.0

0.60

0.59

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.94

0.94

13.3

12.9

105.20

105.09

mmol/l

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

2.18

0.92

12.5

17.3

1.18

1.00

—

(3007164) IgA [Mass/volume] in Serum or Plasma

160

1.59

0.87

1.8

1.9

1.97

2.27

g/l

0.29

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

512

2.14

0.87

26.5

14.1

24.55

23.75

mg/l

0.07

393

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

504

1.93

0.82

14.1

10.8

32.36

23.26

u/l

0.50

484

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

2.27

0.78

4.8

2.5

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

2.27

0.78

4.8

2.5

—

(1761868) Lipid panel - Serum or Plasma

154

0.58

0.77

1.6

2.2

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

164

1.53

0.77

3.1

1.9

88.31

97.36

pmol/l

0.46

(3014007) Fractional oxyhemoglobin in Arterial blood

2.00

0.72

8.2

22.9

95.80

95.39

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

2.00

0.72

6.0

24.9

24.38

mmol/l

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

139

1.53

0.72

2.2

1.9

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.93

0.70

2.2

1.8

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.71

0.69

2.7

1.5

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

106

1.55

0.65

1.8

2.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1.79

0.65

2.2

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

147

0.62

0.64

5.0

3.6

0.00

estimate

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1.72

0.63

1.0

1.1

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.61

0.0

1.8

—

(3035933) Granulocytes/Leukocytes in Blood

0.00

0.61

0.0

1.6

—

53.72

—

(3022313) Gas panel - Capillary blood

1.62

0.61

14.0

11.9

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

0.00

0.61

0.0

1.8

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1.85

0.60

8.5

9.9

101.00

123.76

g/l

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

0.00

0.60

0.0

1.8

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

132

0.63

0.60

2.0

1.9

—

(3009261) Glucose [Presence] in Urine by Test strip

268

1.41

0.60

7.7

4.3

0.00

estimate

—

(3037467) Urinalysis macro (dipstick) panel - Urine

351

1.41

0.55

9.2

5.2

—

(3021601) Nitrite [Presence] in Urine by Test strip

263

1.36

0.51

7.6

4.2

0.00

estimate

—

(3005322) IgE [Units/volume] in Serum or Plasma

1.59

0.50

3.7

1.2

3204.29

69.22

u/ml

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

1.45

0.47

1.0

1.7

—

(3035350) Ketones [Presence] in Urine by Test strip

266

1.34

0.46

7.9

4.3

0.00

estimate

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

114

1.42

0.46

2.2

2.6

—

(40768804) Tissue Pathology biopsy report

170

1.36

0.46

2.6

1.8

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

0.00

0.41

0.0

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.51

0.41

2.0

3.7

—

(1002224) Polysomnography panel

0.00

0.41

0.0

1.0

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

0.00

0.40

0.0

2.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1.38

0.40

2.9

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1.44

0.39

3.0

2.2

—

(3003458) Phosphate [Moles/volume] in Serum or Plasma

100

1.38

0.37

27.3

14.4

1.14

1.30

mmol/l

1.21

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1.47

0.37

1.5

1.6

—

(3003396) Base excess in Arterial blood by calculation

1.44

0.36

8.7

15.9

1.00

-0.28

mmol/l

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

479

1.39

0.35

34.1

17.9

4.00

3.96

mmol/l

0.48

461

(3019550) Sodium [Moles/volume] in Serum or Plasma

481

1.37

0.32

33.9

17.9

139.43

139.31

mmol/l

0.15

466

(3016879) Cocaine [Presence] in Urine

1.33

0.32

1.0

1.7

—

(3029937) Albumin [Presence] in Urine by Test strip

131

1.30

0.31

10.9

4.2

0.00

0.02

estimate

—

(3000764) Benzodiazepines [Presence] in Urine

1.31

0.31

1.0

1.7

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

170

1.26

0.30

2.4

2.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

430

1.28

0.29

4.7

3.9

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

0.69

0.28

2.4

6.8

3.38

2.26

ug/l

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.34

0.26

4.5

1.9

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

1.27

0.23

1.2

1.3

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1.27

0.23

1.6

1.5

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.30

0.22

2.7

1.6

—

(3000475) Leukocytes [#/volume] in Synovial fluid

0.00

0.21

0.0

1.0

—

3419.80

—

(3044941) Cell count panel - Synovial fluid

0.00

0.21

0.0

1.0

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

0.00

0.21

0.0

1.6

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

0.00

0.21

0.0

1.6

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

0.00

0.21

0.0

1.8

—

0.75

—

(3010421) pH of Blood

0.00

0.21

0.0

2.1

—

7.42

—

(3011288) Drugs identified in Urine by Screen method Nominal

1.28

0.21

1.0

1.9

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

1.77

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.00

0.20

0.0

1.1

—

0.98

—

(3027008) Opiates [Presence] in Urine

1.26

0.19

1.0

1.7

—

(3028300) Cannabinoids [Presence] in Urine

1.26

0.19

1.0

1.7

—

(3027944) Amphetamines [Presence] in Urine

1.26

0.19

1.0

1.7

—

(40768797) Stomach Pathology biopsy report

1.23

0.19

1.4

1.2

—

(36660697) Celiac disease serology panel - Serum

1.16

0.17

1.1

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

122

1.19

0.15

5.0

3.8

46.34

89.21

ng/l

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

1.18

0.10

1.2

1.6

3.86

3.22

mmol/l

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1.07

0.09

1.6

1.5

—

(3002256) Pathology report gross observation

1.10

0.09

1.2

—

(3037522) Nuclear Ab [Titer] in Serum

1.04

0.08

1.3

1.4

—

523.33

—

(3015736) pH of Urine

226

1.10

0.08

6.7

3.9

6.46

6.40

0.14

107

(3003694) ABO and Rh group [Type] in Blood

187

1.10

0.07

1.8

1.7

—

(3013512) EKG study

110

0.89

0.05

5.0

3.4

—

(40760892) CBC W Ordered Manual Differential panel - Blood

109

0.90

0.04

10.7

5.4

—

(3044889) 12 lead EKG panel

260

0.93

0.04

4.2

3.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

507

0.92

0.02

31.2

15.9

73.10

64.48

umol/l

0.31

495

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

156

0.95

0.00

1.9

2.0

1.45

1.30

mmol/l

0.21

135

(3019832) Treponema pallidum Ab [Presence] in Serum

127

1.03

0.00

1.7

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

366

1.03

0.00

21.9

11.1

95.09

91.02

ml/min/173m2

0.35

311

(3011985) Renin [Units/volume] in Plasma

0.00

0.0

1.0

—

22.18

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.0

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

0.00

0.0

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

0.00

0.0

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

0.00

0.0

1.3

—

13.17

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

0.00

0.0

1.3

—

(21494434) Karyotype in Bone marrow

0.00

0.0

1.8

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.2

—

36.67

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

0.00

0.0

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

0.00

-0.00

0.0

1.8

—

6.32

—

(3038515) Glucose [Moles/volume] in Venous blood

0.00

-0.00

0.0

4.1

—

6.17

—

(3049717) Cytology report of Urine Cyto stain

0.00

-0.00

0.0

2.1

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

6.6

—

(3028271) Lactate [Moles/volume] in Capillary blood

0.00

-0.00

0.0

1.3

—

1.59

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.4

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

0.00

-0.00

0.0

4.4

—

1.19

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

-0.00

0.0

1.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

0.00

-0.00

0.0

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

-0.00

0.0

4.2

—

(40761511) CBC panel - Blood by Automated count

513

1.09

-0.00

23.8

10.6

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

-0.00

0.0

1.1

—

(3017732) Neutrophils [#/volume] in Blood

0.90

-0.00

3.4

3.1

3.31

4.49

e9/l

—

(3041354) Potassium [Moles/volume] in Venous blood

0.00

-0.00

0.0

4.4

—

3.78

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.2

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.2

—

(3004809) Band form neutrophils/Leukocytes in Blood

0.00

-0.00

0.0

5.4

—

3.00

—

(44813793) Dust mix specific IgE antibody measurement

0.00

-0.00

0.0

1.1

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

213.40

—

(3035285) Chloride [Moles/volume] in Venous blood

0.00

-0.00

0.0

4.4

—

106.20

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(3013336) Amino acids [Identifier] in Serum or Plasma

0.00

-0.00

0.0

1.8

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

2.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1.02

-0.00

2.6

5.7

16.50

22.75

—

(3021788) Differential panel - Synovial fluid

0.00

-0.00

0.0

1.0

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

4.4

—

11.80

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.92

-0.00

1.2

1.7

3.78

3.18

ratio

—

(3000093) Morphology [Interpretation] in Blood Narrative

0.00

-0.00

0.0

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3035715) Granulocytes [#/volume] in Blood

0.00

-0.00

0.0

1.8

—

3.84

—

(3027315) Oxygen [Partial pressure] in Blood

0.00

-0.00

0.0

2.6

—

11.19

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

-0.00

0.0

1.0

—

(3013290) Carbon dioxide [Partial pressure] in Blood

0.00

-0.00

0.0

2.6

—

4.79

—

(3051651) Icteric interference index of Serum or Plasma

0.00

-0.00

0.0

2.6

—

0.75

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

0.00

-0.00

0.0

6.6

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_DIAPER and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_DIAPER.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_DIAPER – Diaper [napkin] dermatitis

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Diaper [napkin] dermatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints